Cavhanza Tablet, Orally Disintegrating
Product Images NDC 70709-192

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cavhanza (NDC 70709-192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cycle Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A Kaplan-Meier survival curve showing treatment-free survival percentage over time since treatment-free remission (TFR) in weeks. The graph includes a survival curve with confidence intervals, censored observations indicated, and a table of patients at risk with event and censorship counts noted below the time axis.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A Kaplan-Meier survival curve chart illustrating treatment-free survival percentage over time since treatment-free remission (TFR) in weeks. The chart includes a solid survival curve with dashed confidence interval lines and marks for censored observations, along with a table indicating patient numbers at risk, events, and censored data at different time points.*
FDA Label Image

60 mg Label (Label 60mg)

60 mg Label (Label 60mg)
CAVHANZA 60 mg orally disintegrating tablets label showing the Nilotinib active ingredient. The label includes storage instructions, quantity of 112 tablets, NDC number 70709-191-12, and marketing information by Cycle Pharmaceuticals Ltd. It cautions about the seal integrity and substitution warning for Nilotinib products.*
FDA Label Image

80 mg Label (Label 80mg)

80 mg Label (Label 80mg)
CAVHANZA 80 mg orally disintegrating tablets label showing active ingredient nilotinib. The label includes storage instructions, dispensing warnings, quantity of 112 tablets, Rx only designation, and marketing by Cycle Pharmaceuticals Ltd, Cambridge, UK. Barcode and NDC 70709-192-12 are visible.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Nilotinib, the active ingredient in CAVHANZA orally disintegrating tablets. The structure shows several aromatic rings, nitrogen atoms, and a trifluoromethyl group (CF3).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.